TRVI- Trevi Therapeutics, Inc.

Name: Trevi Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Trevi Therapeutics, Inc. (TRVI) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 8 sells. TRVI is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Hastings David C	375.0K	$5.56M	-
CEO	Good Jennifer L	156.4K	$2.32M	-
CFO	Delfini Lisa	110.4K	$1.64M	-
Other	Simon Farrell	110.4K	$1.64M	-
Other	Sciascia Thomas	92.0K	$1.36M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 13, 2023	Delfini Lisa52	Chief Financial Officer	Sale+OE	8,474	$2.45	$20,761.30	-26.6%	+7.8%	-24.9%
Jul 5, 2022	Tpg GP A, LLC77	Former 10% Owner	Sell	500,000	$2.89	$1,444,011.81	-6.1%	-51.8%	-29.3%
Jun 30, 2022	Tpg GP A, LLC77	10% Owner	Sell	475,966	$2.77	$1,318,200.87	-5.0%	-38.8%	-14.9%
May 2, 2022	Tpg GP A, LLC77	10% Owner	Sell	600	$2.70	$1,620.00	-	+28.3%	+30.3%
Apr 29, 2022	Tpg GP A, LLC77	10% Owner	Sell	23,434	$2.75	$64,525.16	-0.2%	+24.4%	+27.4%
Apr 11, 2022	Walker Paul Edward46	10% Owner	Buy	3,580,526	$1.90	$6,802,999.40	+46.0%	+31.2%	-32.7%
Apr 11, 2022	Sonsini Peter W.	10% Owner	Buy	3,580,526	$1.90	$6,802,999.40	+46.0%	+31.2%	-32.7%
Apr 11, 2022	Sandell Scott D56	10% Owner	Buy	3,580,526	$1.90	$6,802,999.40	+46.0%	+31.2%	-32.7%
Apr 11, 2022	Makhzoumi Mohamad57	10% Owner	Buy	3,580,526	$1.90	$6,802,999.40	+46.0%	+31.2%	-32.7%
Apr 11, 2022	Florence Anthony A. Jr.57	10% Owner	Buy	3,580,526	$1.90	$6,802,999.40	+46.0%	+31.2%	-32.7%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC